POCT1Survey23 Postcard

Appendix J POCT1Surv23_042415.pdf

Improving the Impact of Laboratory Practice Guidelines: A New Paradigm for Metrics- Clinical and Laboratory Standards Institute

POCT1Survey23 Postcard

OMB: 0920-1088

Document [pdf]
Download: pdf | pdf
Appendix J

Help CLSI and the CDC
CLSI and the CDC are collecting information about awareness of
laboratory practice guidelines (LPGs) and to identify barriers to
their implementation.

The mark ‘CDC’ is owned by the US Dept. of Health and Human Services
and is used with permission. Use of this logo is not an endorsement by
HHS or CDC of any particular product, service, or enterprise.

Mark Your Calendar!

You will receive access to the survey within the next 4–6 weeks.

Participation in this study is voluntary and responses will be anonymous. CLSI will collect and analyze the data and share with CDC.

Who is conducting this study and why?

The Clinical and Laboratory Standards Institute (CLSI) and the Centers
for Disease Control and Prevention (CDC) are conducting this study to
find various ways to improve the impact of LPGs on health care.

NONPROFIT ORG.
U.S. POSTAGE
PAID
Permit No. 140
Southeastern, PA

Why were we selected to participate?

Your facility may potentially perform point-of-care fingerstick glucose
testing.
950 West Valley Road
Suite 2500
Wayne, PA 19087 USA

Who should complete this survey?

The individual at your site who is responsible for developing your
fingerstick glucose testing procedures should complete it.

Why should we respond to this survey?

You can provide valuable information to help CLSI improve the
dissemination and implementation of its LPGs, and to improve the
quality of care provided to all patients in any health care setting.

P: +1.610.688.0100	

Toll Free (US): +1.877.447.1888

F: +1.610.688.0700	

E: [email protected]


File Typeapplication/pdf
File Modified2015-05-06
File Created2015-04-24

© 2024 OMB.report | Privacy Policy